Karison

Clobetasol Propionate, the active ingredient in Karison, is a topical corticosteroid presented as a cream for skin use. It is prescribed to reduce inflammation and scaling in various dermatologic conditions, particularly in adults with moderate to severe disease. It is indicated for short‑term management of plaque psoriasis, atopic dermatitis, seborrheic dermatitis, lichen planus and other inflammatory dermatoses, providing rapid symptom relief.

GNH USA supplies Karison as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution for regulated medicines.

Clobetasol Propionate is used to treat a range of inflammatory skin disorders by markedly reducing redness, scaling, and itching, leading to improved skin integrity. - Psoriasis: diminishes plaque formation and erythema, improving skin appearance and reducing discomfort. - Atopic dermatitis (eczema): alleviates itching and inflammation for faster lesion clearance and promotes healing. - Seborrheic dermatitis: controls scaling and redness on scalp and face while soothing irritation. - Lichen planus: reduces papular lesions and associated discomfort. - Other inflammatory dermatoses: provides anti‑inflammatory relief in conditions such as discoid lupus or contact dermatitis.

Topical application of clobetasol propionate may be associated with a range of local and systemic adverse reactions. Common Side Effects: - Skin irritation: mild burning or stinging at the application site. - Pruritus: transient itching. - Dryness: localized skin dryness or flaking. - Acneiform eruption: emergence of small pimples. Serious or Rare Side Effects: - Skin atrophy: thinning of the epidermis with possible striae. - Telangiectasia: visible small blood vessels. - Secondary infection: bacterial or fungal overgrowth. - Adrenal suppression: systemic glucocorticoid effects with extensive use.

Before using Karison, consider the following safety measures to minimize risks. - Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown excretion; use only if essential. - Children: limit use and duration; monitor for growth effects. - Infected skin: do not apply on bacterial, viral or fungal infections without medical advice. - Long‑term therapy: restrict duration to prevent skin atrophy and systemic absorption. - Store at room temperature: keep in the original container, protect from moisture and light.

Clobetasol propionate can interact with other agents, influencing its efficacy or safety. Major Interactions (Avoid): - Systemic corticosteroids: concurrent use may increase risk of systemic glucocorticoid effects. - Antifungal topicals (e.g., ketoconazole): may reduce steroid potency. - Immunosuppressants (e.g., cyclosporine): may enhance immunosuppression and infection risk. Moderate Interactions (Monitor Closely): - Photosensitizing drugs (e.g., tetracyclines): may increase skin irritation on UV exposure. - Other topical steroids: cumulative potency can raise risk of adverse skin changes. - Live vaccines: topical steroid may diminish local immune response.